For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.

Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...

Biotech has long been one of the strongest sector stories of the past year, and investors who got there early have been rewarded. As of April 2, 2026, the State Street SPDR S&P Biotech ETF (NYSE:XBI) ...

In the highly regulated world of life sciences, quality isn’t a box to check—it’s a business imperative. For global ...

Integrated consulting approach streamlines pathway from concept to commercialization NEW YORK, NY, UNITED STATES, April ...

The upcoming FDA decision for Replimune’s advanced melanoma drug could be a litmus test for the agency's future regulatory ...

Biotech executives, investors, and R&D leaders all face the same burning question in 2026: How do we scale breakthroughs from ...

If Biotech manages to break out to new highs at some point this year, it would clear a significant resistance hurdle and open ...

The companies Earendil Labs, Teva Pharmaceuticals, and Solid Biosciences bagged the biggest biotech funding rounds overall in ...